AML-348 A Phase Ib/II Study of Ivosidenib With Venetoclax +/- Azacitidine in IDH1-Mutated Hematologic Malignancies (2022)

First Author: Lachowiez C
Attributed to:  Biology and Treatment of Human Myeloid Cancers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2152-2650(22)01276-9

Publication URI: https://api.elsevier.com/content/abstract/scopus_id/85138218593

Type: Journal Article/Review

Parent Publication: Clinical Lymphoma Myeloma and Leukemia